Progress in the treatment of secondary hyperparathyroidism in patients undergoing maintenance hemodialysis
10.3760/cma.j.cn341190-20240218-00172
- VernacularTitle:维持性血液透析患者并发继发性甲状旁腺功能亢进症的治疗进展
- Author:
Shu HAN
1
;
Jiamei DI
Author Information
1. 蚌埠医科大学研究生院，蚌埠 233030
- Keywords:
Hyperparathyroidism,secondary;
Kidney diseases;
Kidney failure,chronic;
Renal dialysis;
Hemodiafiltration;
Review
- From:
Chinese Journal of Primary Medicine and Pharmacy
2024;31(7):1111-1115
- CountryChina
- Language:Chinese
-
Abstract:
Secondary hyperparathyroidism is a common complication among patients undergoing maintenance hemodialysis. Approximately 60% of patients with chronic kidney disease exhibit varying degrees of secondary hyperparathyroidism. The control rate of intact parathyroid hormone in these patients remains at approximately 55%. The clinical manifestations of secondary hyperparathyroidism primarily consist of elevated parathyroid hormone levels and persistent calcium and phosphorus metabolism disorders, which can lead to skin, bone, and cardiovascular and cerebrovascular diseases. These conditions significantly affect patients' quality of life and may even lead to increased mortality rates. This article aims to review the progress in the treatment of secondary hyperparathyroidism based on the latest relevant research.
